News
Current position:Product Center > Cell lines > Immune checkpoints > BTLA-HVEM > H_HVEM PD-L1 aAPC CHO-K1 Cell Line
H_HVEM PD-L1 aAPC CHO-K1 Cell Line
Description
Cat. No: GM-C31561
Product: H_HVEM PD-L1 aAPC CHO-K1 Cell Line


BTLA (B and T lymphocyte attenuator) and HVEM (herpesvirus entry mediator) are key immune regulatory proteins that form an important regulatory pathway. BTLA, as an inhibitory co-stimulatory receptor, suppresses T cell activation and immune responses when bound to HVEM.

PD-1 (programmed cell death protein 1) is a receptor on activated T cells, B cells, and NK cells that inhibits T cell activation by binding to its ligands PD-L1 and PD-L2. PD-L1, primarily found on tumor and immune cells, promotes immune evasion. The PD-1/PD-L1 pathway is crucial for regulating immune tolerance and inhibiting autoimmune responses, maintaining immune balance.

The H_HVEM PD-L1 aAPC CHO-K1 Cell Line is a clonal stable cell line that constitutively expresses human HVEM and PD-L1 gene. The cell line is co-cultured with the H_BTLA PD-1 Reporter Cell Line. The binding of BTLA to HVEM and PD-1 to PD-L1 both inhibit T cell signaling. By adding Anti-BTLA and Anti-PD1 antibodies, the interactions of BTLA-HVEM and PD-1-PD-L1 are blocked, thereby restoring T cell signaling. The luciferase readout indicates the activation level of the signaling pathway, allowing evaluation of the in vitro effects of BTLA and PD-1 related drugs.
Data
H_HVEM PD-L1 aAPC CHO-K1 Cell Line (Cat. GM-C31561) was determined by flow cytometry using Anti-TNFRSF14(HVEM) hIgG4 Antibody (Cat. GM-49928AB), Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Cat. GM-31740AB).
The passage stability of the H_HVEM PD-L1 aAPC CHO-K1 Cell Line (Cat. GM-C31561) was determined by flow cytometry using Anti-TNFRSF14(HVEM) hIgG4 Antibody (Cat. GM-49928AB).
The passage stability of the H_HVEM PD-L1 aAPC CHO-K1 Cell Line (Cat. GM-C31561) was determined by flow cytometry using Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Cat. GM-31740AB).
Specifications
Cat. NoGM-C31561
ProductH_HVEM PD-L1 aAPC CHO-K1 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Blasticidin+ 100 μg/mL Hygromycin+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
F12KBOSTER/PYG0036
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
HygromycinGenomeditech/GM-040403
PuromycinGenomeditech/GM-040401
Anti-TNFRSF14(HVEM) hIgG4 AntibodyGenomeditech/GM-49928AB
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab)Genomeditech/GM-31740AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+ 100 μg/mL Hygromycin+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.


Current Position:Product Center > Cell lines > Immune checkpoints > BTLA-HVEM > H_HVEM PD-L1 aAPC CHO-K1 Cell Line
classify
H_HVEM PD-L1 aAPC CHO-K1 Cell Line
Description
Cat. No: GM-C31561
Product: H_HVEM PD-L1 aAPC CHO-K1 Cell Line


BTLA (B and T lymphocyte attenuator) and HVEM (herpesvirus entry mediator) are key immune regulatory proteins that form an important regulatory pathway. BTLA, as an inhibitory co-stimulatory receptor, suppresses T cell activation and immune responses when bound to HVEM.

PD-1 (programmed cell death protein 1) is a receptor on activated T cells, B cells, and NK cells that inhibits T cell activation by binding to its ligands PD-L1 and PD-L2. PD-L1, primarily found on tumor and immune cells, promotes immune evasion. The PD-1/PD-L1 pathway is crucial for regulating immune tolerance and inhibiting autoimmune responses, maintaining immune balance.

The H_HVEM PD-L1 aAPC CHO-K1 Cell Line is a clonal stable cell line that constitutively expresses human HVEM and PD-L1 gene. The cell line is co-cultured with the H_BTLA PD-1 Reporter Cell Line. The binding of BTLA to HVEM and PD-1 to PD-L1 both inhibit T cell signaling. By adding Anti-BTLA and Anti-PD1 antibodies, the interactions of BTLA-HVEM and PD-1-PD-L1 are blocked, thereby restoring T cell signaling. The luciferase readout indicates the activation level of the signaling pathway, allowing evaluation of the in vitro effects of BTLA and PD-1 related drugs.
Data
H_HVEM PD-L1 aAPC CHO-K1 Cell Line (Cat. GM-C31561) was determined by flow cytometry using Anti-TNFRSF14(HVEM) hIgG4 Antibody (Cat. GM-49928AB), Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Cat. GM-31740AB).
The passage stability of the H_HVEM PD-L1 aAPC CHO-K1 Cell Line (Cat. GM-C31561) was determined by flow cytometry using Anti-TNFRSF14(HVEM) hIgG4 Antibody (Cat. GM-49928AB).
The passage stability of the H_HVEM PD-L1 aAPC CHO-K1 Cell Line (Cat. GM-C31561) was determined by flow cytometry using Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab) (Cat. GM-31740AB).
Specifications
Cat. NoGM-C31561
ProductH_HVEM PD-L1 aAPC CHO-K1 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Blasticidin+ 100 μg/mL Hygromycin+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
F12KBOSTER/PYG0036
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
HygromycinGenomeditech/GM-040403
PuromycinGenomeditech/GM-040401
Anti-TNFRSF14(HVEM) hIgG4 AntibodyGenomeditech/GM-49928AB
Anti-H_CD274(PDL1) hIgG1 Antibody(Atezolizumab)Genomeditech/GM-31740AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+ 100 μg/mL Hygromycin+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.


Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit